How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
5
LLLI Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
16.52%
Day range:
$0.0041 - $0.0051
52-week range:
$0.0000 - $0.0089
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
192.38x
P/B ratio:
--
Volume:
51K
Avg. volume:
67.8K
1-year change:
-42.66%
Market cap:
$246K
Revenue:
$10.8K
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Lamperd Less Lethal, Inc. has -- downside to fair value with a price target of -- per share.
LLLI vs. S&P 500
-
Over the past 5 trading days, Lamperd Less Lethal, Inc. has underperformed the S&P 500 by -23.37% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Lamperd Less Lethal, Inc. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lamperd Less Lethal, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Lamperd Less Lethal, Inc. reported revenues of --.
Earnings Growth
-
Lamperd Less Lethal, Inc. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Lamperd Less Lethal, Inc. reported earnings per share of --.
Enterprise value:
1.2M
EV / Invested capital:
--
Price / LTM sales:
192.38x
EV / EBIT:
--
EV / Revenue:
197.63x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-13.23x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $28.9K | $31.3K | $6K | $6.2K | $1.3K | |
| Gross Profit | $23.4K | $25.7K | $1.7K | $4.6K | $200 | |
| Operating Income | -$180.9K | -$116.5K | -$79.7K | -$23.8K | -$23.8K | |
| EBITDA | -$180.9K | -$116.4K | -$79.7K | -$23.8K | -$23.8K | |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $152.4K | $135.3K | $115.6K | $101K | |
| Total Assets | -- | $175.7K | $135.3K | $115.6K | $101K | |
| Current Liabilities | -- | $1.2M | $1.2M | $1.3M | $1.3M | |
| Total Liabilities | -- | $1.2M | $1.2M | $1.3M | $1.3M | |
| Total Equity | -- | -$1M | -$1M | -$1.1M | -$1.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$4.9K | -$91K | -$800 | -$45.7K | |
| Cash From Investing | -- | -$100 | -- | -- | -- | |
| Cash From Financing | -- | -$9.8K | $107.1K | $800 | $64K | |
| Free Cash Flow | -- | -$4.9K | -$91.1K | -$800 | -$45.7K | |
LLLI
Sector
Market Cap
$246K
$499.8M
Price % of 52-Week High
46.07%
83.07%
Dividend Yield
0%
0%
Shareholder Yield
--
1.57%
1-Year Price Total Return
-42.66%
--
Beta (5-Year)
-0.099
0.542
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0048
200-day SMA
Sell
Level
$0.0052
Bollinger Bands (100)
Sell
Level
0.0053 - 0.0053
Chaikin Money Flow
Sell
Level
-29.9K
20-day SMA
Sell
Level
$0.0048
Relative Strength Index (RSI14)
Sell
Level
44.1286
ADX Line
Buy
Level
9.0436
Williams %R
Neutral
Level
-48.2759
50-day SMA
Sell
Level
$0.0049
MACD (12, 26)
Buy
Level
0.0007
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Sell
Level
-27.5K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-112.0311)
Sell
CA Score
(Annual)
Level (-52.6829)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (95.0366)
Sell
Piotroski F Score
(Annual)
Level (3)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lamperd Less Lethal, Inc. engages in the development, manufacture, and international sales company for advanced less lethal weapons, ammunition, and other security products. Its focused markets are the police, correctional, military, and private security forces. It offers police version peppers platter, personal protection, smoke pepper, pepper blast, distraction devices, humane animal control, face shields, launchers, munitions, police riot shields and protective gears, projectile deterrent weapons, and training gears. The company was founded in 1969 and is headquartered in Sarnia, Canada.
Stock Forecast FAQ
In the current month, LLLI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LLLI average analyst price target in the past 3 months is --.
-
Where Will Lamperd Less Lethal, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lamperd Less Lethal, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Lamperd Less Lethal, Inc.?
Analysts are divided on their view about Lamperd Less Lethal, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lamperd Less Lethal, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Lamperd Less Lethal, Inc.'s Price Target?
The price target for Lamperd Less Lethal, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LLLI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lamperd Less Lethal, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of LLLI?
You can purchase shares of Lamperd Less Lethal, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lamperd Less Lethal, Inc. shares.
-
What Is The Lamperd Less Lethal, Inc. Share Price Today?
Lamperd Less Lethal, Inc. was last trading at $0.0000 per share. This represents the most recent stock quote for Lamperd Less Lethal, Inc.. Yesterday, Lamperd Less Lethal, Inc. closed at $0.0041 per share.
-
How To Buy Lamperd Less Lethal, Inc. Stock Online?
In order to purchase Lamperd Less Lethal, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get LLLI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LLLI
Sector
P/E ratio
--
20.18x
PEG ratio
--
0.18x
P/B ratio
--
1.75x
Price / LTM sales
192.38x
0.87x
Growth Metrics
LLLI
Sector
Revenue growth
--
4.67%
Earnings growth
--
4.65%
Revenue (5-year growth)
-35.24%
4.48%
Earnings forecast
--
$0.33
Profitability
LLLI
Sector
Profitability FY 2024
$6.5K
$245.7M
Return on invested capital
--
4.6%
Return on assets
--
3.09%
Return on equity
--
7.95%
Earnings Date
Last Earnings Date
Feb
4
Next Earnings Date
Feb
4
Estimated Next Earnings Date
May
6
Balance Sheet
LLLI
Sector
Total cash
--
$136.3M
Short term investments
--
$31.1M
Total assets
$100.2K
$1.4B
Long term debt
--
$45.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Sell
13
CRVL alert for Feb 4
CorVel Corp. [CRVL] is down 2.25% over the past day.
Buy
62
DVA alert for Feb 4
DaVita, Inc. [DVA] is up 4.28% over the past day.
Sell
26
IT alert for Feb 4
Gartner, Inc. [IT] is down 5.09% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
